The oral route is a preferred method of drug administration, though achieving effective drug
delivery and minimizing off-target side effects is often challenging. Formulation into …

Background Poly (glycolic acid), poly (lactic acid) and poly (lactic-co-glycolic acid) were
approved by the United States Food and Drug Administration (FDA) in the 1970s as …

Poly (lactic-co-glycolic acid)(PLGA) microspheres are a sustained-release drug delivery
system with several successful commercial products used for the treatment of a variety of …

Long acting injectable formulations have been developed to sustain the action of drugs in
the body over desired periods of time. These delivery platforms have been utilized for both …

In situ forming implants, defined as liquid formulations that generate solid or semisolid
depots following administration, have shown a range of advantages in drug delivery. This …

Lipid-based complex injectables are renowned for their effectiveness in delivering drugs,
with many approved products. While significant strides have been made in formulating …

In the present study, in vitro permeation experiments in a Franz diffusion cell were performed
using different synthetic polymeric membranes and pig ear skin to evaluate a rivastigmine …

Long-acting injectable (LAIs) delivery systems sustain the drug therapeutic action in the
body, resulting in reduced dosage regimen, toxicity, and improved patient compliance. Lipid …

Long-acting injectable (LAI) drug products enable the controlled release of a drug over an
extended duration of time to improve the therapeutic effect, safety profile, or administration of …

Introduction Poly (lactic-co-glycolic acid)(PLGA) has been used in many long-acting drug
formulations, which have been approved by the US Food and Drug Administration (FDA) …